India's Ranbaxy shares fall; U.S. FDA revokes approval for some drugs

MUMBAI (Reuters) - India's Ranbaxy Laboratories Ltd fell 4.4 percent in pre-open trading on Friday after the U.S. Food and Drug Administration (FDA) revoked tentative approval for certain generic drugs.

via Reuters: Health News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1E9QbAW